DB Power and LPA announce strategic partnership to globally expand solutions for issuers of structured retail products

Real Time Search
CES A80 :
CES HKMI :
CES 120 :
Total Turn.

02162 KEYMED BIO-B

Closed Add to Porfolio
Index Constituent : HS Composite Index, HS Comp. M & S Index, HS Comp.SmallCap Ind, Stock Connect HK Ind, Stock Connect HK MS, Stock Connect HK S I
Major Shareholders Bo CHEN & Associates (25.16%) Sector Health Care & Biotechnology
Web Site http://www.keymedbio.com Tel (86 28) 8861-0620
Email pr@keymedbio.com Fax N/A
Related Equities N/A
Principal Activities Principally engaged in the inhouse discovery and development of innovative biological therapies in the autoimmune and oncology therapeutic areas.

Consolidated List of Substantial Shareholders

Name Number of Shares Interested % of Issued Share Capital (%) Date of Last Notice Filed (Y/M/D)
Last Update :
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool

Complete List of Directors

Director's Name Number of Shares Interested % of issued share capital (%) Date of Last Notice Filed (Y/M/D)
Last Update :
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool
Back to Top